Literature DB >> 26118429

Aortic dimensions in Turner syndrome.

Emilio Quezada1, Jodi Lapidus2, Robin Shaughnessy1, Zunqiu Chen2, Michael Silberbach1.   

Abstract

In Turner syndrome, linear growth is less than the general population. Consequently, to assess stature in Turner syndrome, condition-specific comparators have been employed. Similar reference curves for cardiac structures in Turner syndrome are currently unavailable. Accurate assessment of the aorta is particularly critical in Turner syndrome because aortic dissection and rupture occur more frequently than in the general population. Furthermore, comparisons to references calculated from the taller general population with the shorter Turner syndrome population can lead to over-estimation of aortic size causing stigmatization, medicalization, and potentially over-treatment. We used echocardiography to measure aortic diameters at eight levels of the thoracic aorta in 481 healthy girls and women with Turner syndrome who ranged in age from two to seventy years. Univariate and multivariate linear regression analyses were performed to assess the influence of karyotype, age, body mass index, bicuspid aortic valve, blood pressure, history of renal disease, thyroid disease, or growth hormone therapy. Because only bicuspid aortic valve was found to independently affect aortic size, subjects with bicuspid aortic valve were excluded from the analysis. Regression equations for aortic diameters were calculated and Z-scores corresponding to 1, 2, and 3 standard deviations from the mean were plotted against body surface area. The information presented here will allow clinicians and other caregivers to calculate aortic Z-scores using a Turner-based reference population.
© 2015 Wiley Periodicals, Inc. © 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Turner syndrome; aortic Z-scores; aortic dissection; bicuspid aortic valve

Mesh:

Year:  2015        PMID: 26118429     DOI: 10.1002/ajmg.a.37208

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

1.  Aortic root dilatation in patients with mucopolysaccharidoses and the impact of enzyme replacement therapy.

Authors:  Fabiano de Oliveira Poswar; Carolina Fischinger Moura de Souza; Roberto Giugliani; Guilherme Baldo
Journal:  Heart Vessels       Date:  2018-08-22       Impact factor: 2.037

2.  The genetic basis of Turner syndrome aortopathy.

Authors:  Holly Corbitt; Jacob Gutierrez; Michael Silberbach; Cheryl L Maslen
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-02-16       Impact factor: 3.908

3.  Heart and Aorta Anomalies in Turner Syndrome and Relation with Karyotype.

Authors:  A D Kardelen Al; G Gencay; Z Bayramoglu; B Aliyev; E Karakilic-Ozturan; S Poyrazoglu; K Nişli; F Bas; F Darendeliler
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

4.  Turner syndrome: French National Diagnosis and Care Protocol (NDCP; National Diagnosis and Care Protocol).

Authors:  Elodie Fiot; Bertille Alauze; Bruno Donadille; Dinane Samara-Boustani; Muriel Houang; Gianpaolo De Filippo; Anne Bachelot; Clemence Delcour; Constance Beyler; Emilie Bois; Emmanuelle Bourrat; Emmanuel Bui Quoc; Nathalie Bourcigaux; Catherine Chaussain; Ariel Cohen; Martine Cohen-Solal; Sabrina Da Costa; Claire Dossier; Stephane Ederhy; Monique Elmaleh; Laurence Iserin; Hélène Lengliné; Armelle Poujol-Robert; Dominique Roulot; Jerome Viala; Frederique Albarel; Elise Bismuth; Valérie Bernard; Claire Bouvattier; Aude Brac; Patricia Bretones; Nathalie Chabbert-Buffet; Philippe Chanson; Regis Coutant; Marguerite de Warren; Béatrice Demaret; Lise Duranteau; Florence Eustache; Lydie Gautheret; Georges Gelwane; Claire Gourbesville; Mickaël Grynberg; Karinne Gueniche; Carina Jorgensen; Veronique Kerlan; Charlotte Lebrun; Christine Lefevre; Françoise Lorenzini; Sylvie Manouvrier; Catherine Pienkowski; Rachel Reynaud; Yves Reznik; Jean-Pierre Siffroi; Anne-Claude Tabet; Maithé Tauber; Vanessa Vautier; Igor Tauveron; Sebastien Wambre; Delphine Zenaty; Irène Netchine; Michel Polak; Philippe Touraine; Jean-Claude Carel; Sophie Christin-Maitre; Juliane Léger
Journal:  Orphanet J Rare Dis       Date:  2022-07-12       Impact factor: 4.303

Review 5.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  Circ Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 8.589

Review 6.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-21       Impact factor: 6.903

7.  Determinants of Increased Aortic Diameters in Young Normotensive Patients With Turner Syndrome Without Structural Heart Disease.

Authors:  A Uçar; Melike Tuğrul; Bülent Oğuz Erol; Ensar Yekeler; Banu Aydın; Seher Yıldız; Kemal Nişli; Firdevs Baş; Şükran Poyrazoğlu; Feyza Darendeliler; Nurçin Saka; Aylin Yetim Şahin; Yasin Yılmaz; Rüveyde Bundak
Journal:  Pediatr Cardiol       Date:  2018-02-01       Impact factor: 1.655

8.  Allometric considerations when assessing aortic aneurysms in Turner syndrome: Implications for activity recommendations and medical decision-making.

Authors:  Holly Corbitt; Cheryl Maslen; Siddharth Prakash; Shaine A Morris; Michael Silberbach
Journal:  Am J Med Genet A       Date:  2017-12-15       Impact factor: 2.802

9.  Long-Term Outcomes in Patients With Turner Syndrome: A 68-Year Follow-Up.

Authors:  Margaret M Fuchs; Christine Attenhofer Jost; Dusica Babovic-Vuksanovic; Heidi M Connolly; Alexander Egbe
Journal:  J Am Heart Assoc       Date:  2019-06-04       Impact factor: 5.501

10.  TIMP3 and TIMP1 are risk genes for bicuspid aortic valve and aortopathy in Turner syndrome.

Authors:  Holly Corbitt; Shaine A Morris; Claus H Gravholt; Kristian H Mortensen; Rebecca Tippner-Hedges; Michael Silberbach; Cheryl L Maslen
Journal:  PLoS Genet       Date:  2018-10-03       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.